FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Myanmar
Energy & Environment
Brexit
North Korea
Charged: The Future of Autos
Future of Money
Breakingviews
Healthcare
March 19, 2018 / 10:27 AM / in a month

BRIEF-Granules India Says U.S. FDA Approves ANDA For Metformin Extended Release Tablets

Reuters Staff

1 Min Read

March 19 (Reuters) - Granules India Ltd:

* USFDA APPROVED ANDA FILED BY CO FOR METFORMIN EXTENDED RELEASE (ER) TABLETS 500 MG AND 750 MG

* SAYS CO INTENDS TO COMMERCIALISE PRODUCT SHORTLY Source text - bit.ly/2GIAtXh Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.